A detailed history of Pictet Asset Management Sa transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 598,918 shares of SAGE stock, worth $3.43 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
598,918
Previous 6,538 9060.57%
Holding current value
$3.43 Million
Previous $274,000 10177.74%
% of portfolio
0.03%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$40.65 - $59.54 $24.1 Million - $35.3 Million
592,380 Added 9060.57%
598,918 $28.2 Million
Q4 2022

Feb 13, 2023

BUY
$32.2 - $43.61 $210,523 - $285,122
6,538 New
6,538 $249,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.